PEDIATRICS Vol. 39 No. 2 February 1967, pp. 313
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FIKRIG, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by FIKRIG, S.

Letters to the Editor

SENIH FIKRIG M.D.1

1 State University of New York, Downstate Medical Center, 450 Clarkson Ave. Brooklyn, New York 11203

While we are aware of the G-6-PD variants, we have not done the specific tests on our patients. Actually, all of the patients with low G-6-PD activity, irrespective of whether they developed hemolysis or not, were Negroes and, therefore, could be classified as B(-) variant. As far as we know this variant had not been implicated in relation to favism or severe neonatal jaundice.

The enzyme variant had also not been specified for the group of patients reported by Kattamis, et al. We agree that factors beside G-6-PD must play a role in hemolytic anemias due to viral or bacterial infections.